Aligning Clinical Development Services With Medical Affairs
Bringing a new therapy from early-phase trials to a fully launched product used to be treated as two distinct projects: one team ran the science, another team managed the message once approval came through. That division is increasingly seen as a costly mistake, which is why sponsors of every size are now investing in dedicated development partners built to work hand-in-hand with the teams responsible for communicating evidence to physicians long before launch day arrives. Why Trial Design and Field Strategy Can No Longer Work in Silos When a clinical trial is designed purely to satisfy regulators, sponsors often discover too late that the data doesn't answer the questions practicing physicians actually ask. Clinical development services play a critical role in ensuring trial designs balance regulatory requirements with real-world clinical needs. A drug can win approval and still struggle commercially if the trial never measured the outcomes that matter most to prescribers and pay...